Shopping Cart
Remove All
Your shopping cart is currently empty
Meseclazone has anti-inflammatory, analgesic, and antipyretic activity. Meseclazone shows inhibitory potency of secondary phase ADP aggregation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Meseclazone has anti-inflammatory, analgesic, and antipyretic activity. Meseclazone shows inhibitory potency of secondary phase ADP aggregation. |
| In vivo | Intravenous administration of Meseclazone, along with other nonsteroidal anti-inflammatory drugs (NSAIDs), has been found to cause a dose-dependent reduction in bronchoconstriction. This leads to a sequence of efficacy in decreasing order as follows: isoproterenol ≈ indomethacin > fenoprofen > tolmetin > aspirin > naproxen ≈ ibuprofen > phenylbutazone > diflunisal > Meseclazone > 5-CSA. Additionally, Meseclazone demonstrates the ability to inhibit collagen-induced platelet aggregation 1 and 4 hours post oral administration[1][2]. |
| Synonyms | W2395, NSC297623 |
| Molecular Weight | 239.65 |
| Formula | C11H10ClNO3 |
| Cas No. | 29053-27-8 |
| Relative Density. | 1.47g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.